Shandong Xinhua Pharmaceutical Company Limited (SHE:000756)
15.67
-0.09 (-0.57%)
Feb 13, 2026, 3:04 PM CST
SHE:000756 Revenue
Shandong Xinhua Pharmaceutical Company had revenue of 2.12B CNY in the quarter ending September 30, 2025, with 6.10% growth. This brings the company's revenue in the last twelve months to 8.49B, up 1.89% year-over-year. In the year 2024, Shandong Xinhua Pharmaceutical Company had annual revenue of 8.47B with 4.51% growth.
Revenue (ttm)
8.49B
Revenue Growth
+1.89%
P/S Ratio
1.07
Revenue / Employee
1.16M
Employees
7,159
Market Cap
9.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.47B | 365.47M | 4.51% |
| Dec 31, 2023 | 8.10B | 597.86M | 7.97% |
| Jan 1, 2023 | 7.50B | 942.91M | 14.37% |
| Dec 31, 2021 | 6.56B | 554.49M | 9.23% |
| Dec 31, 2020 | 6.01B | 399.57M | 7.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Neptunus Bioengineering | 27.28B |
| Harbin Pharmaceutical Group | 15.94B |
| North China Pharmaceutical Company.Ltd | 9.79B |
| KPC Pharmaceuticals,Inc. | 6.58B |
| Shandong Lukang Pharmaceutical | 6.19B |
| Zhejiang Xianju Pharmaceutical | 3.59B |
| Tianjin Ringpu Bio-Technology | 3.37B |
| Zhejiang Tianyu Pharmaceutical | 2.99B |